Baldessari, Cinzia
 Distribuzione geografica
Continente #
NA - Nord America 853
EU - Europa 333
AS - Asia 223
SA - Sud America 4
Totale 1.413
Nazione #
US - Stati Uniti d'America 853
IT - Italia 141
SE - Svezia 69
SG - Singapore 69
CN - Cina 65
HK - Hong Kong 46
GB - Regno Unito 33
DE - Germania 31
IN - India 15
FI - Finlandia 14
ID - Indonesia 14
RU - Federazione Russa 13
BG - Bulgaria 7
FR - Francia 5
NL - Olanda 5
VN - Vietnam 5
CL - Cile 4
BE - Belgio 3
CZ - Repubblica Ceca 3
AT - Austria 2
CH - Svizzera 2
LT - Lituania 2
MY - Malesia 2
AE - Emirati Arabi Uniti 1
ES - Italia 1
IE - Irlanda 1
IL - Israele 1
IR - Iran 1
KH - Cambogia 1
KZ - Kazakistan 1
PK - Pakistan 1
TR - Turchia 1
UA - Ucraina 1
Totale 1.413
Città #
Santa Clara 168
Chandler 126
Fairfield 97
Ashburn 71
Nyköping 59
Singapore 57
Woodbridge 50
Hong Kong 45
Seattle 36
Houston 28
Wilmington 27
Ann Arbor 23
Cambridge 23
New York 20
San Diego 20
Bologna 17
Southend 15
Helsinki 14
Jakarta 14
Bremen 13
Princeton 12
Shanghai 12
Milan 10
Beijing 9
Modena 9
London 8
Dearborn 7
Gurugram 7
Sofia 7
Falls Church 6
Moscow 6
Reggio Calabria 6
Rimini 6
New Delhi 5
Padova 5
Amsterdam 4
Dong Ket 4
Jacksonville 4
Munich 4
Palermo 4
Atlanta 3
Brno 3
Brussels 3
Canegrate 3
Chiaravalle Centrale 3
Chicago 3
Florence 3
Los Angeles 3
Roncoferraro 3
Binasco 2
Bra 2
Brooklyn 2
Caulonia 2
Cornedo Vicentino 2
Cosenza 2
Eugene 2
Fremont 2
Grimma 2
Guangzhou 2
Impruneta 2
Lamezia Terme 2
Lugano 2
Messina 2
Montebello Jonico 2
Nanjing 2
Reggio Emilia 2
Romainville 2
Rome 2
San Giovanni in Persiceto 2
Stockholm 2
Zevio 2
Acton 1
Almaty 1
Ardabil 1
Augusta 1
Bagnara Calabra 1
Bagnara di Romagna 1
Bitonto 1
Boardman 1
Calusco d'Adda 1
Carpi 1
Casalnuovo di Napoli 1
Chiswick 1
Dalmine 1
Dubai 1
Dublin 1
Gunzenhausen 1
Hefei 1
Islamabad 1
Izmir 1
Jiaxing 1
Kilburn 1
Madrid 1
Montalto Uffugo 1
Montélimar 1
Nagold 1
Napoli 1
Newark 1
Norwalk 1
Nuremberg 1
Totale 1.158
Nome #
Nivolumab-Induced Impressive Response of Refractory Pulmonary Sarcomatoid Carcinoma with Brain Metastasis 221
Body composition and inflammation impact in non-small cell lung cancer patients treated by first-line immunotherapy 193
Role of evaluating tumor‑infiltrating lymphocytes, programmed death‑1 ligand 1 and mismatch repair proteins expression in malignant mesothelioma 186
Treating cancer with immunotherapy in HIV-positive patients: A challenging reality 141
Long progression-free survival with cabozantinib in a heavily pretreated patient with metastatic renal cell carcinoma: a case report 92
IDH signalling pathway in cholangiocarcinoma: From biological rationale to therapeutic targeting 86
Long survival of a young patient with Xp11.2 translocation metastatic clear cell renal carcinoma: case report 83
Myocarditis and diaphragmatic rhabdomyolysis with respiratory failure in a patient with metastatic melanoma treated with Nivolumab 74
Unexpected tumor response to palliative pelvic radiotherapy in mismatch repair-deficient advanced prostate cancer: a case report 72
Exceptional response to lurbinectedin and irinotecan in BRCA-mutated platinum-resistant ovarian cancer patient: a case report 72
Cemiplimab- and nivolumab-induced myasthenia gravis: two clinical cases 69
Cabozantinib and nivolumab as first-line treatment in advanced renal cell carcinoma 53
Immune-Checkpoint-Inhibitor-Related Lung Toxicity: A Multicentre Real-Life Retrospective Portrait from Six Italian Centres 52
Successes and failures of angiogenesis blockade in gastric and gastro-esophageal junction adenocarcinoma 40
Totale 1.434
Categoria #
all - tutte 8.932
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 8.932


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/202050 0 0 0 0 0 0 12 12 12 5 7 2
2020/2021214 9 50 18 18 11 12 7 12 10 28 11 28
2021/2022197 13 2 0 11 8 31 5 8 24 23 33 39
2022/2023344 45 50 26 28 39 38 14 50 25 5 10 14
2023/2024235 8 16 18 24 36 25 21 25 10 11 13 28
2024/2025330 28 3 19 54 118 107 1 0 0 0 0 0
Totale 1.434